The stock is also looking quite well from a longer time frame too, as the four week price change compares favorably with the industry at large as well. http://www.theactproject.com/usefuleyesurgeon/2016/09/21/fibbers-of-connective-tissues-which-join-the-muscles-to-the-bones-are-called-tendons/Longer Term Price Change for Pain Therapeutics While any stock can see a spike in price, it takes a real winner to consistently outperform the market. That is why looking at longer term price metricssuch as performance over the past three months or year– and comparing these to an industry at large can be very useful. And in the case of PTIE, the results are quite impressive. The company has beaten out the industry at large over the past 12 weeks by a margin of 30.59% to 11.04% while it has also outperformed when looking at the past year, putting up a gain of45.92%. http://ryanramirezpoint.luminific.com/2016/09/28/commercial-office-property-acre-provided-a-20-million-senior-loan-to-finance-the-acquisition-and-execution-of-the-sponsors-business-plan-for-a-150000-square-foot-office-property-located-in-a-suburb/Clearly, PTIE is riding a bit of a hot streak and is worth a closer look by investors. PTIE Earnings Estimate Revisions Moving in the Right Direction While the great momentum factors outlined in the preceding paragraphs might be enough for some investors, we should also take into account broad earnings estimate revision trends. A nice path here can really help to show us a promising stock, and we have actually been seeing that with PTIE as of late too. Over the past two months,1earning estimate have gone higher compared to none lower for the full year. These revisions have helped to boost the consensus estimate as two months ago PTIE was expected to post a loss of 65 cents/share for the full year, though today it looks to have loss per share of 50 cents for the full year now, representing a solid increase which is something that should definitely be welcomed news to would-be investors. PAIN THERAPEUT Price and Consensus PAIN THERAPEUT Price and Consensus | PAIN THERAPEUT Quote Bottom Line Given these factors, investors shouldnt be surprised to note that we have PTIE as a security with a Zacks Rank #2 (Buy) and a Momentum Score of A.You can see the complete list of todays Zacks #1 Rank (Strong Buy) stocks here. Read More So if you are looking for a fresh pick that has potential to move in the right direction, definitely keep PTIE on your short list as this looks be a stock that is very well-positioned to soar in the near term.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/pain-therapeutics-incredible-momentum-stock-135001417.html
The specimens included other millipedes, but no one had seen anything quite like the handful of fossils that were found there last year by guests to the cliffs. Watch these (only distantly related) millipedes glow in the dark. The fossils are likely one to three different species, says Hannibal, who is helping with the analysis. They will likely fit into the group known as the archipolypods, which means ancient many feet. Members of this group have been found in Illinois, the Czech Republic, Great Britain, and beyond. Although many of the legs of the animals are quite well preserved, their tops are not in good shape. ( See how a millipede toddler learned to walk .) So we dont know what their tops were like, says Hannibal. They might have had spines, like some of their relatives, which look like big bottle brushes. Or they might have had no spines.
For the original version including any supplementary images or video, visit http://news.nationalgeographic.com/2016/09/fossil-millipedes-discovered-bay-of-fundy-joggins-cliff/